Malignant rectal GIST managed with chemotherapy (Imatinib Mesylate) : A case report and a comprehensive review

© 2023 The Authors..

Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors involving the gastrointestinal tract, arising from the interstitial cells of Cajal. GIST comprises about 1% of all GI tumors. Rectal GISTs are rare and comprise of approximately 5% of all GISTs and only 0.1% of rectal tumors are found to be GISTs. Rectal GISTs may be diagnosed incidentally or present with symptoms, including defecation problems, bleeding, and/or pain. We report a case of a 46-year-old male with rectal GIST metastasized to the liver and bilateral lung parenchyma managed by Imatinib Mesylate (IM) regimen. Rectal GIST although being rare, must be considered as a differential diagnosis in a patient presenting with defecatory problems with bleeding.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:19

Enthalten in:

Radiology case reports - 19(2024), 4 vom: 01. Feb., Seite 1424-1431

Sprache:

Englisch

Beteiligte Personen:

Bhusal, Amrit [VerfasserIn]
Kc, Suraj [VerfasserIn]
Yogi, Tek Nath [VerfasserIn]
Gupta, Rakesh Kumar [VerfasserIn]
Kumar, Abhijeet [VerfasserIn]
Khanal, Bhawani [VerfasserIn]
Katwal, Shailendra [VerfasserIn]
Neupane, Durga [VerfasserIn]
Lamichhane, Samikshya [VerfasserIn]
Bhagat, Ranjan [VerfasserIn]

Links:

Volltext

Themen:

Case Reports
Case report
Gastrointestinal stromal tumors
Imatinib Mesylate
Metastasis
Rare
Rectal tumors

Anmerkungen:

Date Revised 01.02.2024

published: Electronic-eCollection

Citation Status PubMed-not-MEDLINE

doi:

10.1016/j.radcr.2023.12.046

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM367831082